Physician profile
Xiaoke Liu
NPI 1528046034
$2,937.32
in general payments reported to CMS, 2019-2025
11 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $36.37 · 2021: $205 · 2022: $304 · 2023: $213 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,419.73 | 2019-2022 | |
| Biosense Webster, INC. | $552.88 | 2021-2025 | Carto 3 |
| Medtronic Vascular, INC. | $453.31 | 2019-2020 | |
| Medtronic, INC. | $226.75 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan |
| Atricure, INC. | $82.45 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.58 | 2019 | |
| Boston Scientific Corporation | $67.51 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.66 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.78 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.67 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaoke Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.